De NVP is partner in het European Data Cooperative (EDC), een gezamenlijk project van de NVP en alle andere private equity en venture capital verenigingen in Europa, waaronder Invest Europe,
De NVP is partner in het European Data Cooperative (EDC), een gezamenlijk project van de NVP en alle andere private equity en venture capital verenigingen in Europa, waaronder Invest Europe,
NVP ESSENTIALS VENTURE CAPITAL - AUTUMN 2024 23 SEPTEMBER 2024 Start | 9:00 uur Location | Carlton - Utrecht Cost | €3.150 'My colleagues have often told me that I should follow the NVP Venture
Invest-NL bestaat sinds een paar jaar. Wat doen jullie allemaal? Leo Holwerda stelt zichzelf en Invest-NL voor. Wij willen Nederland duurzamer en innovatiever maken. We richten ons daarom op de
Originele publicatiedatum: 03/10/2019 De European Venture Philanthropy Association (EVPA) organiseert van 5 tot en met 7 november 2019 haar 15e conferentie, dit keer in Den Haag. Wat betekent venture philanthropy precies
Unlocking New Opportunities with ELTIF 2.0: A Practical Perspective The revised European Long-Term Investment Fund (ELTIF) regulation intends to revolutionize the landscape for fund managers, offering a gateway to market illiquid
SuperReturn Europe - The hub for European private markets 4-7 November 2025 | Hotel Okura, Amsterdam View website Discover new investment opportunities in the mid-market, fundraising, co-investments, private debt, secondaries and more 1,500+ real
IPEM WEALTH February 3-5, 2026 – Palais des Festivals, Cannes, France From February 3 to 5, 2026, the iconic French Riviera will host the 2nd edition of IPEM Wealth, the leading global
The VC Essentials training offers room for interaction and we focus on practical examples as much as possible. The training also offers sufficient opportunities to meet colleagues in an informal
The VC Essentials training offers room for interaction and we focus on practical examples as much as possible. The training also offers sufficient opportunities to meet colleagues in an informal
'There are still so many game changers waiting in biotech.' Every year, EQT Life Sciences invests in five to ten biotech companies that are working on the most revolutionary technologies, says